Laura Brege, Director at Mirum Pharmaceuticals, Inc. (MIRM), sold 34,000 shares at $75.07 ($2.5M) on 2025-09-11, disclosed to the SEC on 2025-09-12.
Open-market sale of $2.5M MIRM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.34 | 15,509 | $1.2M | 45.6% |
| 2 | $74.34 | 15,509 | $1.2M | 45.6% |
| 3 | $75.07 | 1,491 | $112K | 4.4% |
| 4 | $75.07 | 1,491 | $112K | 4.4% |
| Total | $74.40 avg | 34,000 | $2.5M | 100% |
| Filing → |
| ACAD | SELL | 2023-06-14 | $112K | — | Filing → |
| PCRX | SELL | 2023-06-07 | $23K | — | Filing → |
| PCRX | SELL | 2023-04-05 | $285K | — | Filing → |